ZAURITO, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 191
NA - Nord America 120
AS - Asia 94
Continente sconosciuto - Info sul continente non disponibili 35
SA - Sud America 7
AF - Africa 3
Totale 450
Nazione #
RU - Federazione Russa 129
US - Stati Uniti d'America 111
IT - Italia 33
SG - Singapore 24
CN - Cina 18
BD - Bangladesh 17
HK - Hong Kong 16
VN - Vietnam 13
GB - Regno Unito 7
BR - Brasile 4
CA - Canada 4
DE - Germania 4
MX - Messico 4
FR - Francia 3
NL - Olanda 3
ZA - Sudafrica 3
ES - Italia 2
FI - Finlandia 2
IN - India 2
PL - Polonia 2
SE - Svezia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
BO - Bolivia 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
JP - Giappone 1
LV - Lettonia 1
SA - Arabia Saudita 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 415
Città #
Hong Kong 16
San Jose 16
Moscow 15
Council Bluffs 14
Singapore 13
Milan 12
New York 11
Ashburn 9
Dallas 6
Rome 5
Santa Clara 5
Beijing 4
Buffalo 3
Da Nang 3
Hanoi 3
Ho Chi Minh City 3
Atlanta 2
Chicago 2
Chongqing 2
Denver 2
Göttingen 2
Hefei 2
Johannesburg 2
Lari 2
Los Angeles 2
Mexico City 2
Montreal 2
Naples 2
Orem 2
Oudehaske 2
Poplar 2
Trảng Bàng 2
Warsaw 2
Abu Dhabi 1
Amarillo 1
Apodaca 1
Barnet 1
Bexley 1
Bila Tserkva 1
Bắc Ninh 1
Calgary 1
Catania 1
Champlin 1
City of London 1
Columbus 1
Corona 1
Cosenza 1
El Pueblito 1
Emalahleni 1
Falkenstein 1
Frankfurt am Main 1
Garland 1
Girard 1
Gothenburg 1
Haiphong 1
Hialeah 1
Honolulu 1
Houston 1
Kirov 1
La Rioja 1
Lappeenranta 1
Lauterbourg 1
L’Aquila 1
Manassas 1
Merrillville 1
Minneapolis 1
Mumbai 1
New Castle 1
New Orleans 1
North Bergen 1
Pasto 1
Pescara 1
Riga 1
Riyadh 1
San José 1
Santa Cruz de la Sierra 1
Saquarema 1
Savannah 1
Seattle 1
Sicklerville 1
Staten Island 1
Stavropol 1
Stockholm 1
Suqian 1
Surat 1
São Carlos 1
São Luís de Montes Belos 1
Tashkent 1
Tipton 1
Tokyo 1
Toronto 1
Turin 1
Turku 1
Upper Marlboro 1
Valencia 1
Valley Stream 1
Volta Redonda 1
Zurich 1
Totale 237
Nome #
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 124
DNA methylation alterations in prostate cancer: from diagnosis to treatment 104
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional series 77
The added value of artificial intelligence using Quantib Prostate for the detection of prostate cancer at multiparametric magnetic resonance imaging 76
Identifying optimal candidates for active surveillance in low-grade intermediate-risk non-muscle invasive bladder cancer 14
Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non–muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials 11
Optimizing oncological outcomes in high-grade non-muscle invasive bladder cancer: The impact of a surgeon-led treatment pathway 10
The value of maintenance therapy in intermediate-risk non-muscle-invasive bladder cancer 9
Management and recurrence patterns of radiation-induced cystitis with hematuria: a persistent clinical challenge 8
Corrigendum to “Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non–muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials”(European Urology, (2025), (S0302283825048778), 10.1016/j.eururo.2025.12.022) 8
Impact of BCG failure patterns on efficacy of intravesical gemcitabine/docetaxel in high-risk non-muscle-invasive bladder cancer 5
Real-world outcomes of bladder-sparing strategies for BCG-unresponsive non-muscle-invasive bladder cancer: a multicenter study 4
Totale 450
Categoria #
all - tutte 1.658
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.658


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251 0 0 0 0 0 0 0 0 0 0 0 1
2025/2026381 17 13 8 24 33 15 21 50 112 25 34 29
2026/202768 35 33 0 0 0 0 0 0 0 0 0 0
Totale 450